Stanozolol (ST) is a synthetic androgen with high anabolic potential.
Introduction
The research for new strategies and materials to enhance bone repair and/or bone regeneration is a major goal for the management of demanding clinical cases in orthopedics and maxillofacial surgery.
Androgens (or androgenic hormones) can be defined as any natural or synthetic steroid that stimulates or controls the development and maintenance of primary and secondary male characteristics in vertebrates by binding to the androgen receptor AR.
1 Androgens also provide anabolic functions, which result in growth and differentiation of cells and increase in body size. 2 Particularly, they play a significant role in regulating skeletal morphogenesis and maintaining bone homeostasis throughout life. 3, 4 The most abundant circulating androgen in men is testosterone, whose effect in peripheral tissues not only depends on a direct action, but also results from a local enzymatic conversion in different metabolites. 5α-reductase and aromatase are among the most important enzymes responsible for testosterone transformation in bone tissues. 5α-reductase activity reflects in the formation of the potent androgen dihydrotestosterone, while aromatase catalyzes androgen conversion into the estrogen estradiol. Depending on its peripheral conversion, systemically administered testosterone may bind either to the AR (testosterone itself or dihydrotestosterone) or to the estrogen receptors ERα/ERβ (testosterone converted to estradiol), which results in androgenic or estrogenic effects. [5] [6] [7] The anabolic potential of androgens leads to the synthesis of molecules with a low androgenic and high anabolic action, with prolonged activity compared with endogenous androgens: these synthetic testosteronederivative drugs are generally known as anabolicandrogenic steroids (AAS). One of these agents is stanozolol (ST), a non-aromatizable AAS derived from dihydrotestosterone.
Systemic administration of AAS in animal models
provided some encouraging results, showing an overall increase in bone formation and mineralization, as well as improvements in bone density and biomechanical properties. [8] [9] [10] Nevertheless, other investigations reported qualitative alterations in the bone geometry and low bone turnover in response to ST treatment.
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In brief, the overall efficacy and the long-term safety of AAS administration for the osteoporosis therapy and the prevention of fracture risk appears to be at least questionable. 12 Figure 2 .
Alizarin Red S staining confirmed the capacity of SaOS-2 to produce calcified extracellular matrix. The (Figure 4b ).
Gene expression analysis
The gene expression analysis related to osteogenic differentiation revealed differences depending both Nevertheless, further studies are required to validate these data in primary osteoblasts as well GHIACCI G, LUMETTI S, MANFREDI E, MORI D, MACALUSO GM, SALA R
